Clinical Trials Logo

Clinical Trial Summary

The INSPYRE implant is a new range of shoulder hemi-arthroplasty device. It consists of a Pyrocarbon spherical interpositional implant and is indicated in primary surgery to relieve severe pain or significant disability caused by degenerative pathologies. The rotator cuff must be functional.

The aim of this study is to prospectively collect data from consecutive series to implement a Post Marketing Surveillance plan.


Clinical Trial Description

Degenerative shoulder pathologies associated with a functional rotator cuff are currently treated by hemi-arthroplasty or total prosthesis replacement. The choice of surgery process is mainly made according to the status of the glenoid.

Concerning hemi-arthroplasty, two types of humeral prosthesis are usually used: anatomical stems or resurfacing head implants. Both provide good results. Nevertheless with these prostheses, patient can present with post-operative pains due to glenoid erosion, linked to the metallic compounds used in such a prostheses. To face this issue, it was decided to modify the metallic compounds, and in order to mimic the tribological properties of the cartilage, Pyrocarbon (PyC) was found to be the best material.

First application of PyC in a medical device was for cardiac valves in 1969. Currently more than 2 million people live with PyC cardiac valves. Mechanical and physical properties of PyC are in favor of its use in orthopedic surgery; furthermore, its biocompatibility plays an important role in its good acceptability.

As very good results were observed when used in hand and wrist, interposition PyC implant was suggested for shoulder. Another advantage was that such interposition device allowed performing less invasive surgery, a particularly important criteria for young patients.

INSPYRE shoulder prosthesis was then designed as a shoulder interposition implant intended for partial replacement of the gleno-humeral joint. This implant is inserted between the glenoid cartilage and the humeral metaphyseal cavity. It is indicated in primary surgery to relieve severe pain or significant disability caused by degenerative pathologies, e.g., osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, primary and secondary necrosis of the humeral head. The rotator cuff must be functional. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02424760
Study type Observational
Source Tornier, Inc.
Contact
Status Active, not recruiting
Phase
Start date March 2011
Completion date March 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05868148 - Shoulder iDâ„¢ Primary Reversed Glenoid Outcomes Clinical Study
Active, not recruiting NCT03806842 - Easytech Reversed Shoulder System Clinical Study N/A
Active, not recruiting NCT02679352 - SMR Stemless Shoulder Arthroplasty Clinical Study N/A
Recruiting NCT04968405 - Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty N/A
Active, not recruiting NCT02444299 - Aequalis Resurfacing Head Study